In other words, the “two-hit” hypothesis can explain why ARID1A protein expression was retained in all benign endometriosis samples with ARID1A loss-of-function mutations and a portion of clear cell carcinoma with ARID1A loss-of-function mutations. The gene discussed is ARID1A; the disease is endometriosis.